Clinical Trials in Pennsylvania

Showing 12761-12780 of 16,895 trials

Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)

NCT00880100

Multicenter, explorative, phase IIIb, open-label study to assess the efficacy and safety of Ultrase® MT12, in the control of steatorrhea and clinical signs and symptoms of malabsorption in CF children with pancreatic insufficiency (PI). This study is sponsored by Aptalis Pharma (formerly Axcan).

Cystic FibrosisPancreatic Insufficiency

Forest Laboratories49 participantsStarted Apr 2009

Aurora, Colorado, United States • Ann Arbor, Michigan, United States • Grand Rapids, Michigan, United States +12 more locations

COMPLETEDPhase 336 miles

Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

NCT00408317

The purpose of this study is to assess the safety and efficacy of Ultrase® MT20 compared to placebo for the correction of fat and protein malabsorption in participants with cystic fibrosis (CF) and exocrine pancreatic insufficiency (EPI). This study is sponsored by Aptalis Pharma (formerly Axcan).

Cystic FibrosisExocrine Pancreatic Insufficiency

Forest Laboratories36 participantsStarted Nov 2006

Grand Rapids, Michigan, United States • Cleveland, Ohio, United States • Hershey, Pennsylvania, United States +1 more locations

Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)

Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

Find Trials by Condition in Pennsylvania

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

A Multicenter Study of NAP (AL-108) in Schizophrenia

Mouse Allergen and Asthma Intervention Trial

Asthma Phenotypes in the Inner City

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

Pazopanib in Treating Patients With Recurrent Glioblastoma

A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation

Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years

PRO 140 for Human Immunodeficiency Virus Infection

Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder

An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

Individualized Therapy For Asthma in Toddlers

Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?

Vitamin D/Calcium Polyp Prevention Study

Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid Tumors

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Primary Rituximab and Maintenance